314 related articles for article (PubMed ID: 15986139)
21. Inhibition of MAPKs, Myc/Max, NFκB, and hypoxia pathways by Phyllanthus prevents proliferation, metastasis and angiogenesis in human melanoma (MeWo) cancer cell line.
Tang YQ; Jaganath IB; Manikam R; Sekaran SD
Int J Med Sci; 2014; 11(6):564-77. PubMed ID: 24782645
[TBL] [Abstract][Full Text] [Related]
22. Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy.
Dantonio PM; Klein MO; Freire MRVB; Araujo CN; Chiacetti AC; Correa RG
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30166456
[TBL] [Abstract][Full Text] [Related]
23. Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB.
Xie B; Cao K; Li J; Chen J; Tang J; Chen X; Xia K; Zhou X; Cheng Y; Zhou J; Xie H
Oncotarget; 2016 Dec; 7(49):80765-80782. PubMed ID: 27779100
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
25. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
Zhao G; Yin Y; Zhao B
J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
[TBL] [Abstract][Full Text] [Related]
26. RIP1 Kinase Is an Oncogenic Driver in Melanoma.
Liu XY; Lai F; Yan XG; Jiang CC; Guo ST; Wang CY; Croft A; Tseng HY; Wilmott JS; Scolyer RA; Jin L; Zhang XD
Cancer Res; 2015 Apr; 75(8):1736-48. PubMed ID: 25724678
[TBL] [Abstract][Full Text] [Related]
27. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
29. Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151.
Gallagher SJ; Mijatov B; Gunatilake D; Gowrishankar K; Tiffen J; James W; Jin L; Pupo G; Cullinane C; McArthur GA; Tummino PJ; Rizos H; Hersey P
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1126-37. PubMed ID: 24924589
[TBL] [Abstract][Full Text] [Related]
30. Involvement of nuclear factor-kappa B activation in IgE synthesis in human B cells.
Yanagihara Y; Basaki Y; Ikizawa K; Kajiwara K; Koshio T; Akiyama K
J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 2):S224-9. PubMed ID: 8977531
[TBL] [Abstract][Full Text] [Related]
31. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
[TBL] [Abstract][Full Text] [Related]
32. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression.
Takada Y; Ichikawa H; Badmaev V; Aggarwal BB
J Immunol; 2006 Mar; 176(5):3127-40. PubMed ID: 16493072
[TBL] [Abstract][Full Text] [Related]
33. Hypoxic microenvironment as a cradle for melanoma development and progression.
Michaylira CZ; Nakagawa H
Cancer Biol Ther; 2006 May; 5(5):476-9. PubMed ID: 16627974
[TBL] [Abstract][Full Text] [Related]
34. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
[TBL] [Abstract][Full Text] [Related]
35. Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells through the Inhibition of NF-[Formula: see text]B and Mitochondria-Dependent Pathways In Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model In Vivo.
Shiue YW; Lu CC; Hsiao YP; Liao CL; Lin JP; Lai KC; Yu CC; Huang YP; Ho HC; Chung JG
Am J Chin Med; 2016; 44(3):637-61. PubMed ID: 27109154
[TBL] [Abstract][Full Text] [Related]
36. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
[TBL] [Abstract][Full Text] [Related]
37. CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells.
Ueda Y; Su Y; Richmond A
Melanoma Res; 2007 Apr; 17(2):91-103. PubMed ID: 17496784
[TBL] [Abstract][Full Text] [Related]
38. Elastin fragments induce IL-1beta upregulation via NF-kappaB pathway in melanoma cells.
Debret R; Le Naour RR; Sallenave JM; Deshorgue A; Hornebeck WG; Guenounou M; Bernard P; Antonicelli FD
J Invest Dermatol; 2006 Aug; 126(8):1860-8. PubMed ID: 16675961
[TBL] [Abstract][Full Text] [Related]
39. How do chemokine/chemokine receptor activations affect tumorigenesis?
Richmond A; Fan GH; Dhawan P; Yang J
Novartis Found Symp; 2004; 256():74-89; discussion 89-91, 106-11, 266-9. PubMed ID: 15027484
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
